These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 6248125
1. Inhibition of a plasminogen activator from oncogenic virus-transformed mouse cells by rabbit antibodies against the enzyme. Danø K, Nielsen LS, Møller V, Engelhart M. Biochim Biophys Acta; 1980 Jun 05; 630(1):146-51. PubMed ID: 6248125 [Abstract] [Full Text] [Related]
2. Plasminogen activator from cells transformed by an oncogenic virus: inhibitors of the activation reaction. Danø K, Reich E. Biochim Biophys Acta; 1979 Jan 12; 566(1):138-51. PubMed ID: 215232 [Abstract] [Full Text] [Related]
3. The plasma inhibitors of plasminogen activator, studied by a zymographic technique. Booth NA, Anderson JA, Bennett B. Thromb Res; 1985 May 01; 38(3):261-7. PubMed ID: 3161209 [Abstract] [Full Text] [Related]
4. Purification and characterization of a plasminogen activator from mouse cells transformed by an oncogenic virus. Danø K, Moller V, Ossowski L, Nielsen LS. Biochim Biophys Acta; 1980 Jun 13; 613(2):542-55. PubMed ID: 6256003 [Abstract] [Full Text] [Related]
5. Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme. Kaltoft K, Nielsen LS, Zeuthen J, Danø K. Proc Natl Acad Sci U S A; 1982 Jun 13; 79(12):3720-3. PubMed ID: 6808514 [Abstract] [Full Text] [Related]
9. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage. Zhang X, Chaudhry A, Chintala SK. Mol Vis; 2003 Jun 12; 9():238-48. PubMed ID: 12813409 [Abstract] [Full Text] [Related]
12. Monoclonal antibody to human tissue plasminogen activator. Matsuo O, Tanbara Y, Okada K, Bando H, Nagoya T. Thromb Res; 1984 Dec 15; 36(6):517-26. PubMed ID: 6442014 [Abstract] [Full Text] [Related]
13. Antibodies to plasminogen activator inhibit human tumor metastasis. Ossowski L, Reich E. Cell; 1983 Dec 15; 35(3 Pt 2):611-9. PubMed ID: 6418388 [Abstract] [Full Text] [Related]
14. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole. Walker B, Elmore DT. Biochem J; 1984 Jul 01; 221(1):277-80. PubMed ID: 6235806 [Abstract] [Full Text] [Related]
15. Separation of plasminogen activators from human plasma and a comparison with activators from human uterine tissue and urine. Kok P. Thromb Haemost; 1979 Jun 30; 41(4):734-44. PubMed ID: 483246 [Abstract] [Full Text] [Related]
16. An anticatalytic monoclonal antibody to avian plasminogen activator: its effect on behavior of RSV-transformed chick fibroblasts. Sullivan LM, Quigley JP. Cell; 1986 Jun 20; 45(6):905-15. PubMed ID: 3011282 [Abstract] [Full Text] [Related]
17. Studies on interactions between plasminogen activator-containing fluids and avain and murine lymphocytes. Wainberg MA, Cohen SD. Dev Comp Immunol; 1981 Jun 20; 5(4):649-60. PubMed ID: 6274714 [No Abstract] [Full Text] [Related]
18. An inhibitor of plasminogen activator in rabbit endothelial cells. Loskutoff DJ, Edgington TS. J Biol Chem; 1981 May 10; 256(9):4142-5. PubMed ID: 6783654 [Abstract] [Full Text] [Related]
19. Expression of the catalytic activity of plasminogen activator under physiologic conditions. Aggeler J, Risch J, Werb Z. Biochim Biophys Acta; 1981 Jun 11; 675(1):62-8. PubMed ID: 6455162 [Abstract] [Full Text] [Related]
20. Inhibition of plasminogen activator associated with chronic granulomatous inflammation. Goldstein SM, Izaki S, Epstein WL. Thromb Res; 1979 Jun 11; 16(5-6):727-35. PubMed ID: 160627 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]